About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials in Houston | 110 Studies

Clinical Trials LupusHouston

Lupus Clinical Trials in Houston

Find 110 clinical trials for lupus near Houston, Texas. Connect with research centers in your area.

All Lupus trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 110 trials

CompletedA Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus ErythematosusA study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily for 48 weeks in approximately…NCT05856448·Tucson, Arizona and 83 others

PreviousPage 4 of 6Next

Lupus Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)This is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody…NCT06411249·Anniston, Alabama and 108 others

CompletedAn Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in AdultsThe purpose of this study is to evaluate the long-term safety of anifrolumab (MEDI-546) in adults with moderate to severe active systemic lupus erythematosus (SLE).NCT01753193·Birmingham, Alabama and 56 others

CompletedA Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).NCT04433585·La Jolla, California and 111 others

TerminatedA IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus ErythematosusThe main purpose of this study is to assess the efficacy and safety of LY3361237 in participants with at least moderately active systemic lupus erythematosus (SLE).NCT05123586·Mesa, Arizona and 49 others

TerminatedPhase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)The purpose of this study is to test the safety and tolerability of repeated subcutaneous (SC) doses of belimumab in subjects with SLE.NCT00732940·Birmingham, Alabama and 10 others

Active not recruitingEfficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusThis is a multinational, randomized, placebo-controlled, parallel treatment, Phase 2, double-blind, 2 arm study evaluating the efficacy and safety of SAR441344 in comparison with…NCT05039840·Vestavia Hills, Alabama and 72 others

CompletedStudy of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)The primary objective of the study is to confirm the clinical efficacy of epratuzumab in the treatment of subjects with Systemic Lupus Erythematosus (SLE).NCT01261793·Birmingham, Alabama and 132 others

CompletedStudy of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative NephritisThis is a multi-center study to evaluate the safety, tolerability, PK, PD, and clinical activity of itolizumab (EQ001) in subjects with Systemic Lupus Erythematosus with or…NCT04128579·Sun City, Arizona and 24 others

TerminatedA Study of Baricitinib (LY3009104) in Participants With Systemic Lupus ErythematosusThe reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).NCT03616912·Birmingham, Alabama and 183 others

CompletedA Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).NCT03616964·Gilbert, Arizona and 158 others

CompletedA DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)Assessment of PF-06700841 in participants with moderate to severe active, generalized Systemic Lupus Erythematosus (SLE) that have inadequate response to standard of care.NCT03845517·Birmingham, Alabama and 163 others

RecruitingDose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus NephritisThis study is researching a particular group of experimental drugs administered for a short period in the treatment of participants with Lupus Nephritis (LN).NCT06975787·San Francisco, California and 18 others

CompletedA Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321The purpose of this study is to evaluate the long-term safety of A-623 in subjects with SLE.NCT01305746·Birmingham, Alabama and 70 others

CompletedA Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02This is a continuation study to evaluate the long-term safety and efficacy of LymphoStat-B™ in subjects with SLE disease, that completed study LBSL02 and benefitted from treatment.NCT00583362·Birmingham, Alabama and 56 others

Active not recruitingA 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusIn this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with cutaneous lupus erythematosus (CLE).NCT05531565·Anniston, Alabama and 314 others

Active not recruitingA Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel (administered once following lymphodepletion) in patients with active, refractory…NCT06581198·Birmingham, Alabama and 106 others

CompletedActhar Gel for Active Systemic Lupus Erythematosus (SLE)This trial is to study Acthar Gel in participants with active systemic lupus erythematosus (SLE).NCT02953821·Hemet, California and 38 others

TerminatedA Study of Imvotamab in Severe Systemic Lupus ErythematosusThe purpose of this study is to determine the safety and tolerability of imvotamab in patients with severe systemic lupus erythematosus who have failed prior therapies.NCT06041568·San Diego, California and 9 others

CompletedPhase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLEStudy Title A phase 1b/2a multicenter, randomized, double-blind, placebo-controlled study to assess the safety and tolerability, pharmacokinetics and preliminary efficacy of…NCT04643067·Anniston, Alabama and 17 others

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia